11 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18632379 | HUMANIZED ANTI-CD45 ANTIBODIES | CHASE, CAROL ANN | 1646 | Final Rejection | Apr 11, 2024 |
| 18323276 | CALRETICULIN NANOBODIES | SUNSHINE, HANNAH LOUISE | 1647 | Non-Final OA | May 24, 2023 |
| 18146149 | HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | LOCKARD, JON MCCLELLAND | 1647 | Non-Final OA | Dec 23, 2022 |
| 17726296 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | ROGERS, JAMES WILLIAM | 1618 | Final Rejection | Apr 21, 2022 |
| 17702648 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | CUNNINGCHEN, KATHLEEN MARY | 1646 | Non-Final OA | Mar 23, 2022 |
| 17532919 | HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | LOCKARD, JON MCCLELLAND | 1647 | Non-Final OA | Nov 22, 2021 |
| 17606254 | COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES | JONES, DAMERON LEVEST | 1618 | Final Rejection | Oct 25, 2021 |
| 16954105 | COMBINATION IMMUNOTHERAPY AND CHEMOTHERAPY FOR THE TREATMENT OF A HEMATOLOGICAL MALIGNANCY | WELLS, LAUREN QUINLAN | 1622 | Non-Final OA | Jun 15, 2020 |
| 16755590 | ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJUNCTION WITH ACT-BASED CANCER THERAPIES | JOHANSEN, PETER N. | 1644 | Final Rejection | Apr 12, 2020 |
| 16755589 | COMBINATION THERAPY FOR TREATMENT OF A HEMATOLOGICAL DISEASE | BUTTICE, AUDREY L | 1647 | Final Rejection | Apr 12, 2020 |
| 16627872 | TREATMENTS FOR A HEMATOLOGICAL MALIGNANCY | SAMALA, JAGADISHWAR RAO | 1618 | Non-Final OA | Dec 31, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial